Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy
Frontiers in Bioscience-Landmark,
Journal Year:
2025,
Volume and Issue:
30(3)
Published: March 20, 2025
Allergic
disorders
rising
in
prevalence
globally,
affecting
a
substantial
proportion
of
individuals
industrialized
nations.
The
imbalance
the
immune
system,
characterized
by
elevated
allergen-specific
T
helper
2
(Th2)
cells
and
immunoglobulin
E
(IgE)
antibodies,
is
key
factor
allergy
development.
Allergen-specific
immunotherapy
(AIT)
only
treatment
capable
alleviating
allergic
symptoms,
preventing
new
sensitizations,
reducing
asthma
risk
rhinitis
patients.
Traditional
AIT,
however,
faces
challenges
such
as
frequent
administration,
adverse
effects,
inconsistent
patient
outcomes.
Nanoparticle-based
approaches
have
emerged
promising
strategy
to
enhance
AIT.
This
review
explores
utilization
nanoparticles
highlighting
their
ability
interact
with
system
improve
therapeutic
Various
types
nanoparticles,
including
polyesters,
polysaccharide
polymers,
liposomes,
protamine-based
(NPs),
polyanhydrides,
been
employed
adjuvants
or
carriers
AIT’s
efficacy
safety.
Nanoparticles
offer
advantages
allergen
protection,
improved
response
modulation,
targeted
cell
delivery,
reduced
side
effects.
provides
an
overview
current
landscape
nanoparticle-based
immunotherapy,
discussing
its
potential
revolutionize
compared
traditional
immunotherapy.
Language: Английский
Expression of serum miR‐135a in patients with allergic rhinitis and its relationship with Treg/Th17 balance
Jing Cai,
No information about this author
Fang Wang,
No information about this author
Shengjun Shi
No information about this author
et al.
The Kaohsiung Journal of Medical Sciences,
Journal Year:
2024,
Volume and Issue:
41(1)
Published: Dec. 11, 2024
The
dysregulation
of
microRNA
(miRNA)
expression
contributes
to
the
development
allergic
rhinitis
(AR).
This
study
investigates
serum
miR-135a
levels
and
their
association
with
regulatory
T
cell
(Treg)
helper
17
(Th17)
balance
in
AR
patients.
A
total
93
patients
76
healthy
controls
were
retrospectively
recruited.
Levels
miR-135a,
peripheral
blood
Th17
Treg
cells,
Treg/Th17-related
cytokines
measured.
We
assessed
diagnostic
value
for
its
relationship
Treg/Th17
balance.
showed
significantly
elevated
immunoglobulin
E
(IgE),
IL-17
IL-6
levels,
alongside
reduced
IL-10,
TGF-β1,
ratios.
≤0.536
demonstrated
potential
AR.
Patients
higher
displayed
increased
level
ratios,
cell,
lower
nasal
symptom
score
(TNSS).
Serum
negatively
correlated
TNSS,
IL-17,
IL-6,
percentages,
positively
Collectively,
decreased
are
associated
balance,
supporting
as
a
biomarker
diagnosis.
Language: Английский